Executive Summary 

• The Make America Healthy Again (MAHA) Commission recently released a report that identifies some root causes of chronic disease in children; its resultant declarative statements often exceed scientific consensus, however, suggesting a comparative review is warranted. 
• As outlined in the report, the United States has seen an increase in chronic disease over the past 40 years; more than 40 percent of U.S. school-aged children live with at least one chronic health condition, while broader analyses suggest the share of youth with a long-term limitation has climbed to nearly 30 percent over the past two decades. 
• Causal relationships remain difficult to substantiate; however, there is evidence to suggest that key claims by the MAHA assessment are accepted in some form by the larger scientific community. 

Introduction 

The recently released Make America Healthy Again (MAHA) Assessment has drawn attention because of its sweeping narrative on the childhood chronic disease crisis. Yet the underlying question for policymakers is simpler: How do the report’s causal claims compare to peer-reviewed evidence and long-standing scientific surveillance? 

Chronic conditions, defined as illnesses that last a year or more and require ongoing care, now dominate the American health landscape. Six in 10 adults carry at least one such diagnosis, and four in 10 juggle multiple conditions – figures that help explain why life expectancy, though up slightly to 78.4 years in 2023, remains well below pre-pandemic levels and lags behind most peer nations. 

In a similar manner, childhood chronic disease has shifted from a marginal concern to a mainstream public health priority. Today, more than 40 percent of U.S. school-aged children live with at least one chronic health condition, while broader analyses suggest the share of youth with a long-term limitation has climbed to nearly 30 percent over the past two decades.  

The burden is concentrated in a handful of conditions that are rising in tandem. Obesity now affects 21.1 percent of children ages 2–19 – up from 13.9 percent at the turn of the century – with severe obesity doubling to 7 percent. Asthma remains the most common chronic lung disease, touching 4.7 million children (roughly one in 15) in 2021. Metabolic illness is emerging earlier: Centers for Disease Control and Prevention (CDC) modeling indicates that, if current trends continue, pediatric type 2 diabetes could climb another 70 percent by mid-century. Meanwhile, the mental health dimension of chronic disease is unmistakable: 10 percent of children aged 3–17 have an anxiety diagnosis, 7 percent a behavioral disorder, and 4 percent depression – and these conditions often interact with and exacerbate somatic illness. 

To appropriately address this issue, it is important to ensure that policymakers, medical professionals, and the concerned public are in general agreement on the identity and magnitude of the problem. To that end, it is necessary to thoroughly analyze the recently released MAHA assessment.  

Compare and Contrast: MAHA Report and the State of Chronic Disease 

A centerpiece of the MAHA assessment is the exponential growth of the U.S. chronic disease burden, which it claims is unrecognized by the medical establishment and enabled by the slow, bureaucratic policy process at the federal level. Yet it opens with generally accepted figures that mirror the CDC’s headline statistics, underscoring that the report and federal policy priorities start from the same dataset. The baseline burden of chronic disease is largely uncontested by most stakeholders in the health care sector. 

Health Area	Alignment With CDC/National Academies	Where MAHA Pushes Further
Diet/Nutrition	Agrees that poor diet underlies obesity and metabolic disease	Targets specific additives (seed oils, dyes) as causal
Physical Inactivity	Fully aligned	Frames screen time itself – not just sedentariness – as metabolic toxin
Chemical Exposures	Acknowledges growing but mixed evidence	Elevates PFAS, glyphosate, and micro-plastics to tier-one drivers
Over-Medicalization	Not a staple CDC risk factor	Asserts medication overuse fuels chronic disease
Sleep and Stress	Consistent with emerging data	Gives these factors parity with diet and activity

Diet and Ultra-processed Foods 

What MAHA says: The report foregrounds ultra-processed foods (UPFs) – especially those rich in industrial seed oils, refined sugars, and artificial additives – as central engines of childhood obesity, type 2 diabetes, fatty-liver disease, and even early puberty. The assessment uses the NOVA system, an internationally accepted food-processing classification, to define UPFs. The assessment also highlights the absence of explicit federal action to label or restrict UPFs, referencing global peers who, in contrast, explicitly advise against UPF consumption. The assessment further urges aligning Supplemental Nutrition Assistance Program and school-meal standards with “whole-food” criteria and hints at restricting soda purchases with nutrition benefits. 

What broader evidence says: CDC and National Institutes of Health (NIH) data long ago identified poor nutrition as a core risk behavior underlying obesity, cardiovascular disease, and several cancers. The latest CDC brief shows adult obesity at 40.3 percent during 2021–2023, with prevalence above 35 percent in 22 states. Where MAHA goes beyond consensus is its focus on specific ingredients (seed oils, artificial sweeteners) rather than macronutrient balance, sodium, or added sugars – the factors most national dietary guidelines highlight. Evidence linking particular additives to population-level chronic disease remains emergent and mixed. 

Large surveillance studies leave little doubt that UPFs dominate the U.S. diet. Analysis of the 2017–18 National Health and Nutrition Examination Survey finds that 54–57 percent of all adult calories now come from UPFs, up from about 51 percent in 2003, with minimal variation by sex, income, or education. Further studies support these UPF observations: UPFs are energy-dense, rapidly digested, and often combine emulsifiers, synthetic sweeteners, or flavor enhancers that may affect hunger and appetite. Still, questions remain: Some studies link UPFs to obesity while others find null associations once total calories are controlled, and the Agricultural Research Service at the U.S. Department of Agriculture has shown it is possible to construct a nutrient-adequate diet that is composed of more than 90 percent UPF.  

Verdict: The literature and the MAHA assessment agree on the central importance of diet, but MAHA’s ingredient-specific indictments make stronger claims than other peer-reviewed, published data. While the MAHA assessment frames UPFs as a relatively recent development, it does overlook how they evolved from earlier forms of processed foods, such as canned and shelf-stable products, through advancements in food science. Yet its critique of federal reluctance to address UPFs in alignment with global trends favoring processing-based dietary guidance rather than ingredient-based guidance is not unfounded.  

Chemical Exposures (PFAS, Glyphosate, Microplastics) 

What MAHA says: A section of the assessment labels chemicals such as per- and poly-fluoroalkyl substances (PFAS), phthalates, bisphenols, and glyphosate-based herbicides as “silent drivers” of metabolic, immune, and neuro-developmental disorders, calling current Environmental Protection Agency standards “obsolete for pediatric safety.” It also argues that American children are chronically exposed to a high cumulative load of synthetic chemicals – over 40,000 registered for use in the United States – through food, water, and air, posing potential neurodevelopmental and endocrine risks. 

What broader evidence says: The National Institute of Environmental Health Sciences and Endocrine Society both recognize PFAS as endocrine disruptors with plausible links to metabolic dysfunction, though with inconclusive dose-response data for most chronic outcomes. Ties to chronic disease from glyphosate are weaker still: A recent review commissioned by Massachusetts calls current evidence “suggestive but not sufficient” for causal claims beyond certain cancers. While compounds such as PFAS and phthalates are potentially but not conclusively linked to developmental harm, cumulative exposure risks remain understudied. 

A 2024 U.S. cross-sectional study of 6,700 adults found PFAS co-exposures associated with higher waist circumference but no consistent metabolic-syndrome composite effect, while a 2023 narrative review cataloged more than 80 studies and concluded that evidence for causal links to diabetes and obesity is “suggestive but insufficient” pending longitudinal replication. Furthermore, there are some studies that document systemic inflammatory responses due to the presence of microplastics: A 2024 review links high micro-plastic burdens with hypertension, diabetes, and stroke but emphasizes that current findings are associated, derived from small cohorts, and prone to confounding by co-pollutants.  

Verdict: The MAHA assessment elevates chemical exposure from “emerging concern” to primary culprit. The mainstream view accepts this potential risk but still ranks diet, physical activity, and tobacco use higher in the causal hierarchy. The assessment’s framing may overstate harm of the U.S’ 40,000 chemical inventory, but it validly highlights that many industrial substances remain poorly studied despite potential links to long-term pediatric health risks.  

Physical Inactivity and Digital-age Sedentary Time 

What MAHA says: Citing survey data finding that more than 70 percent of children (6–17 years old) fall short of federal activity guidelines and that teens log roughly nine hours of recreational screen time daily, the report frames “movement deficiency” and “dopamine-driven digital addiction” as a twin epidemic. 

What broader evidence says: Physical inactivity is one of four canonical CDC risk behaviors for chronic disease. U.S. accelerometer (a device to measure physical movement) studies confirm that most adolescents do not achieve 60-minute activity targets. In fact, only 24–28 percent of U.S. high-school students and 20 percent of adults meet the federal 60-minutes-per-day youth guideline or the 150-minutes-per-week adult target.  

Estimates of average daily screen use are close to seven hours and 22 minutes for teens overall, spiking above nine hours in lower-income households. The association between screen exposure and obesity is well documented, but causal pathways (e.g., displaced sleep, the effects of blue light) remain under investigation. A meta-analysis of 232,000 children across eight countries indicates that each additional hour of recreational screen media is associated with a higher BMI z-score and a rise in metabolic-syndrome odds. While causation remains under debate, potential candidates include a corresponding lack of physical activity, UPF consumption, altered circadian rhythms, and dopamine-affected appetite changes. Federal guidance thus treats screen exposure as a modifiable correlation rather than an independent metabolic toxin, whereas MAHA frames it as a primary driver on par with diet. 

Verdict: There is a strong agreement on the role insufficient activity plays as a driver of children’s disease issues. MAHA’s framing of screen time as a primary metabolic toxin rather than an obesity co-factor takes a bolder stance than most federal guidance. The report’s explanation of screen time likely over-assumes teens’ average daily screen time by a considerable margin. 

Over-medicalization of Childhood 

What MAHA says: The report criticizes growing reliance on pharmaceuticals over foundational health behaviors, citing a doubling of pediatric antidepressant and stimulant prescriptions since 2010. It questions whether medication should be a first-line response, highlighting, for example, that despite a 250-percent increase in U.S. stimulant prescriptions for ADHD from 2006–2016, these medications have not demonstrated long-term academic or behavioral benefits.  

What broader evidence says: Multiple studies confirm sharp rises in antidepressant dispensing to adolescents, up 40–60 percent in many high-income countries over the past decade. CDC surveillance notes that 7.8 percent of U.S. children aged 3–17 took medication for emotional or behavioral problems in 2019, up from 5.5 percent a decade earlier; an analysis in Pediatrics recorded a 63-percent jump in antidepressant dispensing to youths. The clinical community is divided: Some see appropriate recognition of unmet mental health needs; others fear over-diagnosing normal distress. The CDC stops short of calling the trend a chronic-disease driver, focusing instead on the direct link between depression and chronic physical conditions. Studies also find increases in the dispensing of stimulant medications to adolescents. While stimulants are found to have only short-term benefits and no effect on long-term outcomes, the study cited in the assessment identifies various reasons beyond stimulant efficacy that may play a role in impact, such as symptom abatement, medication adherence, and ultimate discontinuation. 

Notably, longitudinal data linking early exposure to later metabolic or autoimmune disease are almost nonexistent, so the claim that “over-medication causes chronic disease” remains speculative in the peer-reviewed literature, even as concerns about side-effect profiles and increased pharmaceutical usage grow. 

Verdict: MAHA’s critique of “pill-first medicine” emphasizes the burden that pharmaceutical interventions can create, but extends beyond the CDC’s established causal model, which treats mental health as a comorbidity rather than a root cause. The MAHA report also inserts itself in the discussion on the efficacy of medication for adolescents, citing, for example, the underwhelming long-term effects of stimulant drugs, but the report fails to note many potential reasons behind the lack of long-term efficacy, some of which implicate factors other than the medications themselves.   

Sleep and Psychosocial Stress 

What MAHA says: The report singles out chronic sleep restriction and social media-induced anxiety, particularly among adolescent girls, as accelerants of metabolic, cardiovascular, and immune dysfunction.  

What broader evidence says: CDC data show that one-third of adults and three-quarters of high schoolers fail to obtain recommended sleep, with short sleep tied to obesity, diabetes, hypertension, and depression. Large cohort studies also link chronic stress and frequent mental distress with shorter life expectancy and higher chronic-disease prevalence, though mechanistic pathways are still being evaluated.  

CDC’s 2021 Youth Risk Behavior Surveillance indicates that 75–84 percent of high-schoolers sleep less than the recommended eight hours, and about one-third of U.S. adults average less than seven hours – a prevalence essentially unchanged since 2010. A 2021 meta-analysis (2.1 million participants across various study cohorts) ranked short sleep among the top three modifiable risk factors for incident type 2 diabetes. Other studies that emphasized sleep restriction experiments document impaired insulin sensitivity and inflammatory immune responses within a week. 

Person-level pooled analyses from a cross-sectional study observing atherosclerosis and other comorbidities show that high chronic stress trajectories lead to a 40–60 percent higher hazard for cardiovascular events over 10 years, independent of smoking and socioeconomic status. Still, reverse causation (early atherosclerosis leading to perceived stress) and individuality and variability in measuring this should lead to uncertain causality, prompting guideline committees to label stress a “probable” rather than “established” risk. 

Verdict: Here MAHA largely reflects emerging consensus – adequate sleep and low stress matter – but gives them equal billing with diet and activity, a weighting not yet universally accepted in federal prevention guidelines. 

Conclusion 

The cumulative impact of childhood chronic disease is felt far beyond the clinic. Chronic disease drives school absenteeism, limits participation in physical and social activities, and inflates family health-care costs that compound economic hardship. Without sustained intervention, today’s patterns portend an adult population entering the workforce with higher baseline morbidity. MAHA’s headline risk factors overlap with – but also go beyond – the center-of-gravity consensus: Diet quality, physical activity, and sleep dominate the broadly accepted causal pyramid, while chemicals, digital media, and overuse of pharmaceuticals remain active research frontiers rather than settled science. Reversing the trajectory will require concerted action across prevention, early detection, and the social determinants that shape risk.